1. Yuan, Ziming, Zhong, Yuchen, Hu, Hanqing, Zhang, Weiyuan, Wang, Guiyu. 2023. DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis. In Frontiers in oncology, 12, 1064376. doi:10.3389/fonc.2022.1064376. https://pubmed.ncbi.nlm.nih.gov/36686789/
2. López-Nevado, Marta, González-Granado, Luis I, Ruiz-García, Raquel, Neth, Olaf, Allende, Luis M. 2021. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. In Frontiers in immunology, 12, 671755. doi:10.3389/fimmu.2021.671755. https://pubmed.ncbi.nlm.nih.gov/34447369/
3. Liew, Phui-Ly, Fang, Chih-Yeu, Lee, Yu-Chieh, Chen, Chi-Long, Chu, Jan-Show. 2016. DEF6 expression in ovarian carcinoma correlates with poor patient survival. In Diagnostic pathology, 11, 68. doi:10.1186/s13000-016-0518-y. https://pubmed.ncbi.nlm.nih.gov/27488395/